102932-05-8

Basic information

• Product Name: 4-bromo-2-chlorophenyl acetate
• CAS NO: 102932-05-8
• Molecular Formula: C₈H₆BrClO₂
• Molecular Weight: 249.489
• Mol File: 102932-05-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 284.6°C at 760 mmHg
• Flash Point: 125.9°C
• Density: 1.607g/cm³
• Vapor Pressure: 0.00294mmHg at 25°C
• Refractive Index: 1.559
• CAS DataBase Reference: 4-bromo-2-chlorophenyl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-chlorophenyl acetate(102932-05-8)
• EPA Substance Registry System: 4-bromo-2-chlorophenyl acetate(102932-05-8)

Safety Data

• Hazardous Substances Data: 102932-05-8(Hazardous Substances Data)

Upstream product

• 3964-56-5 4-bromo-2-chlorophenol 
• 75-36-5 acetyl chloride 
• 95-57-8 2-monochlorophenol 
• 108-24-7 acetic anhydride 
• 108-95-2 phenol 

Relevant articles and documents

Polymerizable liquid crystal compound

PROBLEM TO BE SOLVED: To provide a polymerizable compound giving high refractive index anisotropy, a wide liquid crystal phase temperature range and high storage stability to a liquid crystal composition and producing a polymer film having high pattern resolution, high heat resistance, and little haze and white irregularity when polymerizing the liquid crystal composition. SOLUTION: The polymerizable compound is represented by general formula (I). The polymerizable liquid crystal composition contains the polymerizable compound as a structural member. COPYRIGHT: (C)2013,JPOandINPIT

MODULATORS OF DOPAMINE NEUROTRANSMISSION

The present invention relates to novel 1-(2,3-dihydro-1,4-benzodioxin-2-yl)- methanamine derivatives, useful as modulators of dopamine neurotransmission, and more specifically as dopaminergic stabilizers. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.